News

DST initiates study to identify biomarkers to predict progression from non-severe to severe COVID 19 cases

The approach is to differentiate between the mild and severe cases of COVID-19 based on the determination of biomarkers from detailed metabolome or proteome investigations.

Read More

Apr 16, 2020

By : Team ABLE

AstraZeneca initiates CALAVI clinical trial withanti-blood cancer drug Calquence against COVID-19

The trial design is based upon strong scientific evidence supporting the role of the Bruton’s tyrosine kinase (BTK) pathway in the production of inflammatory cytokines and on encouraging early clinical data.

Read More

Apr 16, 2020

By : Team ABLE

BGI boosts production to bring COVID-19 detection and intervention to over 80 countries including India

In addition, BGI has donated over 130,000 test kits, while partner organizations have donated another 178,000 of BGI's test kits.

Read More

Apr 16, 2020

By : Team ABLE

Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

Sanofi and GSK will combine innovative technologies to develop an adjuvanted COVID-19 vaccine.

Read More

Apr 15, 2020

By : Team ABLE

Bill Gates, GV, and Foresite help Cerevance close $45 million in Series B financing

Cerevance will use the proceeds of the financing to continue identifying novel therapeutic targets for central nervous system diseases, such as Alzheimer’s disease.

Read More

Apr 15, 2020

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights